09.04.24 -- The CDMO Chase Has Gone Digital. Is It Safe?

This article shares new market research on pharma/biotech cleanroom technologies, including regional trends, prominent vendors in the space, and more.

Partnering with a CDMO that offers robust E&L studies can help facilitate a smooth product launch by ensuring minimal impact from impurities, all while mitigating risks.

Discover examples of visible particle identification and the root cause investigation, along with a discussion of additional troubleshooting using innovative technologies.

Medication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development.

Nasal spray administration offers advantages over oral and IV delivery. Experts discuss the advantages and opportunities of adopting unit- and bi-dose nasal delivery technology.

Explore how a solvent-free alternative for amorphous solid dispersions (ASDs) not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.

Highly potent materials bring additional challenges to manufacturing processes. Examine considerations for optimizing HPAPI production methods to reduce risk and deliver therapies to patients with speed.

The growing need for convenient and tamper-free packaging has proliferated the demand for blister packaging. Learn about contract blister packaging services that can produce several different packaging forms.

We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.

Learn how our process analytical technology helps to increase efficiency and examine how our flexible manufacturing capabilities are poised to support your journey from clinical phases to commercialization.